Literature DB >> 31377417

Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response.

Colin T Shearn1, Blair Fennimore2, David J Orlicky3, Yue R Gao2, Laura M Saba4, Kayla D Battista2, Stefanos Aivazidis4, Mohammed Assiri4, Peter S Harris4, Cole Michel4, Gary F Merrill5, Edward E Schmidt6, Sean P Colgan2, Dennis R Petersen4.   

Abstract

Cholangiopathies such as primary sclerosing cholangitis (PSC) are chronic liver diseases characterized by increased cholestasis, biliary inflammation and oxidative stress. The objective of this study was to elucidate the impact of cholestatic injury on oxidative stress-related factors. Using hepatic tissue and whole cell liver extracts (LE) isolated from 11-week old C57BL/6J (WT) and Mdr2KO mice, inflammation and oxidative stress was assessed. Concurrently, specific targets of carbonylation were assessed in LE prepared from murine groups as well as from normal and human patients with end-stage PSC. Identified carbonylated proteins were further evaluated using bioinformatics analyses. Picrosirius red staining revealed extensive fibrosis in Mdr2KO liver, and fibrosis colocalized with increased periportal inflammatory cells and both acrolein and 4-HNE staining. Western blot analysis revealed elevated periportal expression of antioxidant proteins Cbr3, GSTμ, Prdx5, TrxR1 and HO-1 but not GCLC, GSTπ or catalase in the Mdr2KO group when compared to WT. From immunohistochemical analysis, increased periportal reactive aldehyde production colocalized with elevated staining of Cbr3, GSTμ and TrxR1 but surprisingly not with Nrf2. Mass spectrometric analysis revealed an increase in carbonylated proteins in the Mdr2KO and PSC groups compared to respective controls. Gene ontology and KEGG pathway analysis of carbonylated proteins revealed a propensity for increased carbonylation of proteins broadly involved in metabolic processes as well more specifically in Rab-mediated signal transduction, lysosomes and the large ribosomal subunit in human PSC. Western blot analysis of Rab-GTPase expression revealed no significant differences in Mdr2KO mice when compared to WT livers. In contrast, PSC tissue exhibited decreased levels of Rabs 4, 5 and increased abundance of Rabs 6 and 9a protein. Results herein reveal that cholestasis induces stage-dependent increases in periportal oxidative stress responses and protein carbonylation, potentially contributing to pathogenesis in Mdr2KO. Furthermore, during early stage cholestasis, there is cell-specific upregulation of some but not all, antioxidant proteins.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholestasis; Inflammation; Liver; Oxidative stress; Protein carbonylation; Reactive aldehyde

Mesh:

Substances:

Year:  2019        PMID: 31377417      PMCID: PMC6848778          DOI: 10.1016/j.freeradbiomed.2019.07.036

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  78 in total

Review 1.  Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.

Authors:  Kirsten Boonstra; Ulrich Beuers; Cyriel Y Ponsioen
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

2.  The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane.

Authors:  Ivan Ivetac; Adam D Munday; Marina V Kisseleva; Xiang-Ming Zhang; Susan Luff; Tony Tiganis; James C Whisstock; Tony Rowe; Phillip W Majerus; Christina A Mitchell
Journal:  Mol Biol Cell       Date:  2005-02-16       Impact factor: 4.138

3.  Increased hepatocellular protein carbonylation in human end-stage alcoholic cirrhosis.

Authors:  C T Shearn; D J Orlicky; L M Saba; A H Shearn; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2015-10-27       Impact factor: 7.376

4.  Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.

Authors:  Jittima Weerachayaphorn; Albert Mennone; Carol J Soroka; Kathy Harry; Lee R Hagey; Thomas W Kensler; James L Boyer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-16       Impact factor: 4.052

Review 5.  Will we ever model PSC? - "it's hard to be a PSC model!".

Authors:  Marion J Pollheimer; Michael Trauner; Peter Fickert
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-06-23       Impact factor: 2.947

6.  Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.

Authors:  Johannes R Hov; Kirsten M Boberg; Eli Taraldsrud; Mette Vesterhus; Maria Boyadzhieva; Inger Camilla Solberg; Erik Schrumpf; Morten H Vatn; Benedicte A Lie; Øyvind Molberg; Tom H Karlsen
Journal:  Liver Int       Date:  2016-09-13       Impact factor: 5.828

Review 7.  Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling.

Authors:  Hongzhao Li; Aaron J Marshall
Journal:  Cell Signal       Date:  2015-05-27       Impact factor: 4.315

8.  Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine.

Authors:  A Pastor; P S Collado; M Almar; J González-Gallego
Journal:  J Hepatol       Date:  1997-08       Impact factor: 25.083

9.  Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems.

Authors:  Kosuke Okada; Junichi Shoda; Keiko Taguchi; Jonathan M Maher; Kaoru Ishizaki; Yoshimi Inoue; Makio Ohtsuki; Nobuharu Goto; Hirokazu Sugimoto; Hirotoshi Utsunomiya; Koji Oda; Eiji Warabi; Tetsuro Ishii; Masayuki Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  2009-09-02       Impact factor: 3.575

Review 10.  Primary sclerosing cholangitis.

Authors:  Gideon M Hirschfield; Tom H Karlsen; Keith D Lindor; David H Adams
Journal:  Lancet       Date:  2013-06-28       Impact factor: 79.321

View more
  2 in total

1.  Supplemental Ascorbate Diminishes DNA Damage Yet Depletes Glutathione and Increases Acute Liver Failure in a Mouse Model of Hepatic Antioxidant System Disruption.

Authors:  Colin G Miller; Jean A Kundert; Justin R Prigge; Julie A Amato; Allison E Perez; Lucia Coppo; Gabrielle N Rizzo; Michael P Kavanaugh; David J Orlicky; Colin T Shearn; Edward E Schmidt
Journal:  Antioxidants (Basel)       Date:  2021-02-27

Review 2.  The Nrf2 Pathway in Liver Diseases.

Authors:  Jiaming Zhou; Qiuxian Zheng; Zhi Chen
Journal:  Front Cell Dev Biol       Date:  2022-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.